The alternative text for this image may have been generated using AI. Fig. 2: Key examples of medium-scale SV induced by genome editing. The alternative text for this image may have been generated ...
CRISPR-based genome editing therapeutics are entering the clinic, offering transformative potential but also presenting potential risks. Preclinical-to-clinical toolkits are needed to assess the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results